Search
for
Sort by
Research 781–810 of 1000+
- Tissue insulin sensitivity and body weight in polycystic ovary syndrome
- Antiandrogens: Clinical applications
- An Update on Plant Derived Anti-Androgens
- Surrogate end-points or primary outcomes in clinical trials in women with polycystic ovary syndrome?
- Shorter CAG repeats in the androgen receptor gene may enhance hyperandrogenicity in polycystic ovary syndrome
- Prevalence of Polycystic Ovary Syndrome in Girls Aged 14–18 Years in Isfahan, Iran
- Local and Systemic Reduction by Topical Finasteride or Flutamide of Hamster Flank Organ Size and Enzyme Activity
- Gonadotropin-Releasing Hormone Agonist Treatment in Postmenopausal Women with Hyperandrogenism of Ovarian Origin
- Pregnancy and the Skin
- Evaluation of affective temperament and anxiety–depression levels of patients with polycystic ovary syndrome
- Physiological Skin Changes During Pregnancy
- When should an insulin sensitizing agent be used in the treatment of polycystic ovary syndrome?
- Cutaneous manifestations of anabolic-androgenic steroid use in athletes
- Azasteroids as inhibitors of testosterone 5α-reductase in mammalian skin
- What every physician should know about polycystic ovary syndrome
- The Development and Evaluation of An Ovulation Inhibitor (Diane®) Containing An Antiandrogen
- Understanding and Addressing Hair Disorders in Transgender Individuals
- Best Practice Options for Hair Removal in Patients with Unwanted Facial Hair Using Combination Therapy with Laser: Guidelines Drawn up by an Expert Working Group
- Becker's nevus associated with chromosomal mosaicism and congenital adrenal hyperplasia
- Identifying genes associated with the development of human polycystic ovary syndrome
- Skin Academy: Hair, skin, hormones and menopause – current status/knowledge on the management of hair disorders in menopausal women
- European Consensus on the evaluation of women presenting with excessive hair growth
- TrichoScan: combining epiluminescence microscopy with digital image analysis for the measurement of hair growth in vivo.
- Management of the Female With Non-classical Congenital Adrenal Hyperplasia (NCCAH): A Patient-Oriented Approach
- Diagnosis and Challenges of Polycystic Ovary Syndrome in Adolescence
- Pharmacologic Modulation of Sebaceous Gland Activity: Mechanisms and Clinical Applications
- Androgens and Anti-androgen Therapy
- Clinical characteristics of polycystic ovary syndrome: investigating differences in White and South Asian women
- Beneficial Effects of Astragaloside IV for Hair Loss via Inhibition of Fas/Fas L-Mediated Apoptotic Signaling
- Full investigation of patients with polycystic ovary syndrome (PCOS) presenting to four different clinical specialties reveals significant differences and undiagnosed morbidity